BioSpace News Archive

Oyster Point Pharma, Inc. (Nasdaq: OYST), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of first-in-class pharmaceutical therapies to treat ocular surface diseases, announced the positive top-line results from its Phase 1 “ZEN” study in healthy volunteers.

Persons who inherit Li-Fraumeni syndrome (LFS) have an extremely increased risk of developing cancer. For instance, females with the syndrome have a 50% chance of developing cancer by the age of 30 and a 90% chance over their lifetime; males with the syndrome have a 70% chance of cancer over their lifetime.

Auxly Cannabis Group Inc. (TSX.V - XLY) (OTCQX: CBWTF) (“Auxly” or the “Company”) today released its financial results for the three and nine months ended September 30, 2019

The global dental braces market size is poised to grow by USD 1.34 billion during 2019-2023, according to a new report by Technavio, progressing at a CAGR of close to 8% during the forecast period.

Intent Solutions, an Atlanta-based company that provides technology to secure medications and track prescription adherence, is collaborating with AT&T to integrate LTE-M cellular technology into the new release of Intent’s tad™ dispensing system.

NextGate, the global leader in healthcare enterprise identification, announced today it has been recognized as a ‘Notable Next-Generation Enterprise Master Patient Index (EMPI) Vendor’ in a new report from Gartner, Inc.

The iQ Group Global, an enterprise dedicated to developing early stage bioscience assets, announced today that it has made another high-profile appointment.

VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, today announced the presentation of interim data from Part B of the ongoing Phase 1/2a study of VBI-1901, its cancer vaccine immunotherapeutic candidate, in recurrent glioblastoma (GBM) patients in a poster presentation at the 24th Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology (SNO).

AdaptHealth Corp. (NASDAQ: AHCO; AHCOW) (“AdaptHealth” or the “Company”), the third largest home medical equipment (HME) provider in the United States, today announced it has entered into a definitive agreement to acquire the Patient Care Solutions (PCS) business from McKesson Corporation.

Varian (NYSE: VAR) today announced updates to its previously reported GAAP preliminary financial results for its fourth quarter and full fiscal year 2019